IDEAS ITN

IDEAS is a European training network for early stage researchers working on statistical methods for early drug development.

[IDEAS ITN @IDEAS_ITN]

Congratulations to Nico for winning the Arthur Linder price.

https://t.co/gBmDQFP5RF

[IDEAS ITN @IDEAS_ITN]

Lancaster University in global elite as linguistics department ranks 12th in world https://t.co/vZ1gCB2zyX

[IDEAS ITN @IDEAS_ITN]

PhD success for our researcher Marius Thomas @Novartis. He successfully defended his work @TU_Dortmund. We wish you all the best for the future Marius!
#H2020 #MSCA #PhDSuccess #clinicaltrials #statistics

[IDEAS ITN @IDEAS_ITN]

Huge congratulations to our researcher @haiyan_zheng who has successfully defended her PhD @LancsUniMaths @LancasterUni. We wish you all the best for the future Haiyan!
#H2020 #MSCA #PhDSuccess #clinicaltrials #statistics

[IDEAS ITN @IDEAS_ITN]

Merry Christmas and Happy New Year to all our ESRs, partners and followers!
#H2020 #MSCA #nearly2019already

[IDEAS ITN @IDEAS_ITN]

Huge congratulations to our researcher Saswati Saha who has been awarded her PhD "magna cum laude" from the University of Bremen @UniBremen We wish you all the best for the future Saswati!
#H2020 #MSCA #PhDSuccess #clinicaltrials #statistics

[IDEAS ITN @IDEAS_ITN]

Huge congratulations to our researcher Jose Jiménez @jljimenez89 who has successfully defended his PhD thesis at the Politecnico di Torino in Italy @PoliTOnews . Find out more about his research here:
https://t.co/2TibvgdyaW
#H2020 #MSCA #ResearchImpactEU

[IDEAS ITN @IDEAS_ITN]

#IDEAS researcher Nicolas Ballarini @nicoballarini concludes the day's talks with a presentation on "Graphical approaches for subgroup analysis in clinical trials". Many thanks to hosts The Medical University of Vienna @MedUni_Wien!
#h2020 #MSCA

[IDEAS ITN @IDEAS_ITN]

In #Vienna today? Join #IDEAS and the International Biometric Society @IBSstats for our joint seminar at the Medical University of Vienna @MedUni_Wien from 12.30 this afternoon! The full agenda and abstracts can be found below:
https://t.co/5jqwvY1Xnq
#MSCA #H2020 #statistics

[IDEAS ITN @IDEAS_ITN]

Prof. Thomas Jaki @thomas_jaki, based at @LancsUniMaths gives the keynote talk "The IDEAS network: Training and research under one umbrella" at the #IDEAS/IBS joint seminar this afternoon at the Medical University of Vienna @MedUni_Wien
#MSCA #H2020 #statistics #clinicaltrials

[IDEAS ITN @IDEAS_ITN]

In #Vienna today? Join #IDEAS and the International Biometric Society @IBSstats for our joint seminar at the Medical University of Vienna @MedUni_Wien from 12.30 this afternoon! The full agenda and abstracts can be found below:
https://t.co/5jqwvY1Xnq
#MSCA #H2020 #statistics

[IDEAS ITN @IDEAS_ITN]

In #Vienna today? Join #IDEAS and the International Biometric Society @IBSstats for our joint seminar at the Medical University of Vienna @MedUni_Wien from 12.30 this afternoon! The full agenda and abstracts can be found below:
https://t.co/5jqwvY1Xnq
#MSCA #H2020 #statistics

[IDEAS ITN @IDEAS_ITN]

One week today! Join #IDEAS researchers and partners for this great event at the Medical University of Vienna @MedUni_Wien
More details inc. the full programme and abstracts can be found on our website:
https://t.co/LNJskDZMJI …
#MSCA #H2020 #statistics #clinicaltrials

[IDEAS ITN @IDEAS_ITN]

Join IDEAS at our joint seminar with IBS on 29/11/208 at the Medical University of Vienna @MedUni_Wien
Full programme and abstracts can be found here:
https://t.co/5jqwvY1Xnq …
More details available on our website at:
https://t.co/LNJskDZMJI
#MSCA #H2020 #TravelTuesday

[IDEAS ITN @IDEAS_ITN]

Don't forget to book your place at this fantastic event hosted by #IDEAS partner, the Medical University of Vienna @MedUni_Wien!
More details inc. the full programme and abstracts can be found on our website:
https://t.co/LNJskDZMJI
#MSCA #H2020

[IDEAS ITN @IDEAS_ITN]

Join IDEAS at our joint seminar with IBS on 29/11/208 at the Medical University of Vienna @MedUni_Wien
Full programme and abstracts can be found here:
https://t.co/5jqwvY1Xnq …
More details available on our website at:
https://t.co/LNJskDZMJI
#MSCA #H2020 #TravelTuesday

[IDEAS ITN @IDEAS_ITN]

Further press coverage of our ESR Nicolas Ballarini's latest publication just released by the Austrian Press Agency @apa_at. Discover more below (in German):
https://t.co/5A350PMBmR
#H2020 #MSCA #ResearchImpactEU

[IDEAS ITN @IDEAS_ITN]

Check out the new publication by our ESR Nicolas Ballarini @nicoballarini on "Subgroup identification in clinical trials via the predicted individual treatment effect" in PLOS ONE!
https://t.co/7B2Jo5R059
#ResearchImpactEU #H2020 #MSCA #congratulations

[IDEAS ITN @IDEAS_ITN]

Great press coverage for our ESR Nicolas Ballarini's @nicoballarini latest publication by the Medical University of Vienna @MedUni_Wien (in English and German) below:
https://t.co/pWsWvxyZfM
https://t.co/9OshDmyCup
#H2020 #MSCA #ResearchImpactEU

[IDEAS ITN @IDEAS_ITN]

Check out the new publication by our ESR Nicolas Ballarini @nicoballarini on "Subgroup identification in clinical trials via the predicted individual treatment effect" in PLOS ONE!
https://t.co/7B2Jo5R059
#ResearchImpactEU #H2020 #MSCA #congratulations

[IDEAS ITN @IDEAS_ITN]

Join IDEAS at our joint seminar with IBS on 29/11/208 at the Medical University of Vienna @MedUni_Wien
Full programme and abstracts can be found here:
https://t.co/5jqwvY1Xnq …
More details available on our website at:
https://t.co/LNJskDZMJI
#MSCA #H2020 #TravelTuesday

[IDEAS ITN @IDEAS_ITN]

Great to see #IDEAS reunited at the Early Phase Adaptive Trials Workshop in LA!
#MSCA #H2020 #ResearchImpactEU #TravelTuesday

[Haiyan Zheng @haiyan_zheng]

Yesterday enjoying great talks by @pmozgunov and @thomas_jaki at the Early Phase Adaptive Trials Workshop! So delighted about our reunion in LA as well! @IDEAS_ITN

[IDEAS ITN @IDEAS_ITN]

Congratulations to our researcher Pavel Mozgunov, @pmozgunov on his latest publication!
#H2020 #MSCA #ResearchImpactEU

[Pavel Mozgunov @pmozgunov]

Our recent work with @thomas_jaki and Xavier Paoletti on a randomised dose-escalation design for dual-agent oncology trials with an immunotherapy is now available in Open Access. Interested in questions beyond MTD selection in Phase I? Check it out! https://t.co/7pXIS1C0lE

[IDEAS ITN @IDEAS_ITN]

Check out the new publication by our ESR Nicolas Ballarini @nicoballarini on "Subgroup identification in clinical trials via the predicted individual treatment effect" in PLOS ONE!
https://t.co/7B2Jo5R059
#ResearchImpactEU #H2020 #MSCA #congratulations

[IDEAS ITN @IDEAS_ITN]

Huge congratulations to our ESR Maria-Athina Altzerinakou, based @Inserm, who has been awarded her PhD Magna cum laude (with great honour) by the Université Paris-Saclay in France.
https://t.co/eIjCeEyy7k
#researchimpactEU #H2020 #MSCA

[IDEAS ITN @IDEAS_ITN]

Congratulations to our ESR Enya @LancsUniMaths on her publication "Quantifying the association between progression‐free survival and overall survival in oncology trials using Kendall's Tau" in Statistics in Medicine
https://t.co/kgWlTiPExr
#researchimpactEU #H2020 #MSCA